Non-functioning tumours of the pancreas in MEN1 patients

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 3, 2007, Pages 295-296

  Triponez, Frederic ^a,c   Cadiot, Guillaume ^b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; GASTRIN; GLUCAGON; INSULIN; PANCREAS POLYPEPTIDE; PENTETREOTIDE; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL MASS; ALGORITHM; BILE DUCT OBSTRUCTION; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EDITORIAL; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PANCREAS TUMOR; STOMACH OBSTRUCTION; TREATMENT INDICATION; TUMOR DIAGNOSIS; TUMOR SCINTISCANNING; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE; ZOLLINGER ELLISON SYNDROME;

ALGORITHMS; ENDOSONOGRAPHY; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34948892120     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Akerstrom G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg 2002; 386:558-569.
2. Cadiot G, Vuagnat A, Doukhan I, et al. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 1999; 116:286-293.
3. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 2001; 234:495-505; discussion 505-506.
4. Kann PH, Balakina E, Ivan D, et al. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopie ultrasound imaging study. Endocr Relat Cancer 2006; 13:1195-1202.
5. Thomas-Marques L, Murat A, Delemer B, et al. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 2006; 101:266-273.
6. Tonelli F, Fratini G, Falchetti A, Nesi G, Brandi ML. Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. J Intern Med 2005; 257:38-49.
7. Hausman MS Jr., Thompson NW, Gauger PG, Doherty GM. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 2004; 136:1205-1211.
8. Triponez F, Goudet P, Dosseh D, et al. Is surgery beneficial for MENl patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 2006; 30:654-62; discussion 663-664.
9. Blansfield J, Choyke L, Morita S, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease manifested by pancreatic neuroendocrine tumors. Congress of the American Association of Endocrine Surgery (AAES) 2007:Abstract available at http://www.endocrinesurgery. org/mtgs/AAES07abstracts.pdf.